|
OMIM |
Link |
Information gain |
01 |
|
immunoneurologic disorder, x-linked
|
[NCBI]
|
0.00127744
|
|
|
apnea, obstructive sleep
|
[NCBI]
|
0.000861723
|
|
|
keratosis palmoplantaris papulosa
|
[NCBI]
|
0.000761393
|
|
|
ANON1
|
[NCBI]
|
0.000702392
|
|
|
PARK3
|
[NCBI]
|
0.000657571
|
|
|
proteus syndrome
|
[NCBI]
|
0.000542465
|
|
|
SLE
|
[NCBI]
|
0.000505803
|
|
|
KLK3
|
[NCBI]
|
0.000160533
|
|
|
sickle cell anemia
|
[NCBI]
|
0.000135502
|
|
|
kifafa seizure disorder
|
[NCBI]
|
9.19308e-05
|
|
|
melanoma, uveal
|
[NCBI]
|
8.32468e-05
|
|
|
CMD3A
|
[NCBI]
|
8.14987e-05
|
|
|
endocardial fibroelastosis
|
[NCBI]
|
7.47419e-05
|
|
|
carney triad
|
[NCBI]
|
6.97307e-05
|
|
|
RA
|
[NCBI]
|
6.58881e-05
|
|
|
iron overload in africa
|
[NCBI]
|
5.7163e-05
|
|
|
aspirin resistance
|
[NCBI]
|
5.7163e-05
|
|
|
immunoosseous dysplasia, schimke type
|
[NCBI]
|
5.7163e-05
|
|
|
methylmalonic aciduria and homocystinuria, cblc type
|
[NCBI]
|
5.12547e-05
|
|
|
PIGA
|
[NCBI]
|
5.07485e-05
|
|
|
RTT
|
[NCBI]
|
4.77549e-05
|
|
|
APOE
|
[NCBI]
|
4.67202e-05
|
|
|
pancreatic carcinoma
|
[NCBI]
|
4.20828e-05
|
|
|
brugada syndrome 1
|
[NCBI]
|
4.20828e-05
|
|
|
MEN1
|
[NCBI]
|
3.9301e-05
|
|
|
HPS
|
[NCBI]
|
3.8888e-05
|
|
|
ehlers-danlos syndrome, type iv, autosomal dominant
|
[NCBI]
|
3.67599e-05
|
|
|
ALMS
|
[NCBI]
|
3.60093e-05
|
|
|
temporal arteritis
|
[NCBI]
|
3.58009e-05
|
|
|
polycystic kidneys
|
[NCBI]
|
3.45448e-05
|
|
|
DKC
|
[NCBI]
|
3.32937e-05
|
|
|
HIGM1
|
[NCBI]
|
3.04116e-05
|
|
|
AD
|
[NCBI]
|
2.90086e-05
|
|
|
BTHS
|
[NCBI]
|
2.84177e-05
|
|
|
HSAN3
|
[NCBI]
|
2.70674e-05
|
|
|
EDMD
|
[NCBI]
|
2.62264e-05
|
|
|
TAZ
|
[NCBI]
|
2.5499e-05
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
2.50034e-05
|
|
|
PWS
|
[NCBI]
|
2.44776e-05
|
|
|
EMD
|
[NCBI]
|
2.35088e-05
|
|
|
AFP
|
[NCBI]
|
2.34502e-05
|
|
|
NPC1
|
[NCBI]
|
2.22708e-05
|
|
|
SLC1A2
|
[NCBI]
|
2.05457e-05
|
|
|
porphyria variegata
|
[NCBI]
|
2.02069e-05
|
|
|
CHH
|
[NCBI]
|
2.02069e-05
|
|
|
APC
|
[NCBI]
|
2.01481e-05
|
|
|
COL3A1
|
[NCBI]
|
1.92499e-05
|
|
|
MYH7
|
[NCBI]
|
1.85923e-05
|
|
|
ASS
|
[NCBI]
|
1.61099e-05
|
|
|
CPB2
|
[NCBI]
|
1.47995e-05
|
|
|
WHS
|
[NCBI]
|
1.36113e-05
|
|
|
CDLS1
|
[NCBI]
|
1.36113e-05
|
|
|
MECP2
|
[NCBI]
|
1.28499e-05
|
|
|
CASR
|
[NCBI]
|
1.24892e-05
|
|
|
hemophilia a
|
[NCBI]
|
1.21184e-05
|
|
|
CMH
|
[NCBI]
|
1.19217e-05
|
|
|
NF1
|
[NCBI]
|
9.64309e-06
|
|
|
LAM
|
[NCBI]
|
9.6283e-06
|
|
|
ADM
|
[NCBI]
|
9.54272e-06
|
|
|
MAP2
|
[NCBI]
|
9.3097e-06
|
|
|
BCHE
|
[NCBI]
|
8.85663e-06
|
|
|
MBL2
|
[NCBI]
|
8.48971e-06
|
|
|
EIG
|
[NCBI]
|
8.35412e-06
|
|
|
SMAX1
|
[NCBI]
|
7.87285e-06
|
|
|
ACE
|
[NCBI]
|
6.65052e-06
|
|
|
PD
|
[NCBI]
|
5.71099e-06
|
|
|
HD
|
[NCBI]
|
5.16672e-06
|
|
|
MPO
|
[NCBI]
|
4.91316e-06
|
|
|
TTR
|
[NCBI]
|
4.34271e-06
|
|
|
AR
|
[NCBI]
|
4.2427e-06
|
|
|
TNFRSF11B
|
[NCBI]
|
4.14075e-06
|
|
|
GAPDH
|
[NCBI]
|
3.95521e-06
|
|
|
HBB
|
[NCBI]
|
3.74812e-06
|
|
|
CJD
|
[NCBI]
|
3.70805e-06
|
|
|
BDNF
|
[NCBI]
|
3.53349e-06
|
|
|
CEACAM5
|
[NCBI]
|
3.48443e-06
|
|
|
GDNF
|
[NCBI]
|
3.2656e-06
|
|
|
TG
|
[NCBI]
|
2.87555e-06
|
|
|
MFS
|
[NCBI]
|
2.66831e-06
|
|
|
MJD
|
[NCBI]
|
2.29894e-06
|
|
|
AVP
|
[NCBI]
|
2.29865e-06
|
|
|
G6PD
|
[NCBI]
|
2.21693e-06
|
|
|
CFTR
|
[NCBI]
|
8.41201e-07
|
|
|
PTH
|
[NCBI]
|
8.2698e-07
|
|
|
AT
|
[NCBI]
|
6.5398e-07
|
|
|
TNF
|
[NCBI]
|
6.31843e-07
|
|
|
VEGF
|
[NCBI]
|
6.12032e-07
|
|
|
FTD
|
[NCBI]
|
4.51359e-07
|
|
|
CRC
|
[NCBI]
|
3.49748e-07
|
|
|
MG
|
[NCBI]
|
3.37766e-07
|
|
|
ALD
|
[NCBI]
|
2.87216e-07
|
|
|
CF
|
[NCBI]
|
2.77347e-07
|
|
|
MDD
|
[NCBI]
|
1.13556e-07
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
6.83469e-08
|
|
|
EPO
|
[NCBI]
|
3.13282e-08
|
|
|
GFAP
|
[NCBI]
|
1.90656e-08
|
|